These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4382849)

  • 41. Prophylaxis of venous thromboembolism by aspirin, warfarin and heparin in patients with hip fracture. A prospective clinical study with cost-benefit analysis.
    Alho A; Stangeland L; Røttingen J; Wiig JN
    Ann Chir Gynaecol; 1984; 73(4):225-8. PubMed ID: 6439100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recognition and management of deep vein thrombosis.
    Dodson TF
    Heart Dis Stroke; 1993; 2(3):231-4. PubMed ID: 8137030
    [No Abstract]   [Full Text] [Related]  

  • 43. The efficacy of low-dose heparin--warfarin anticoagulation prophylaxis after total hip replacement arthroplasty.
    Goss TP; Stinchfield FE; Cosgriff SW
    Clin Orthop Relat Res; 1979 Jun; (141):134-7. PubMed ID: 477094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Warfarin.
    N Engl J Med; 1984 Dec; 311(24):1578-80. PubMed ID: 6504088
    [No Abstract]   [Full Text] [Related]  

  • 45. Thrombolytic therapy for deep vein thrombosis.
    Persson AV; Persson CA
    Am J Surg; 1985 Oct; 150(4A):50-3. PubMed ID: 4051121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Massive tissue necrosis can be induced by heparin or warfarin.
    Ritchie AJ; Hart NB
    Ulster Med J; 1991 Oct; 60(2):248-50. PubMed ID: 1785165
    [No Abstract]   [Full Text] [Related]  

  • 47. Fibrinolytic treatment of postoperative deep venous thrombosis.
    Giercksky KE; Sorlie DG; Odegaard H; Johnson JA
    Surg Gynecol Obstet; 1975 Oct; 141(4):576-8. PubMed ID: 1166385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
    Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
    N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Empiric use of anticoagulant and fibrinolytic agents in surgical therapy.
    Laufman H
    Am Surg; 1974 Jan; 40(1):15-21. PubMed ID: 4808618
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevention of recurrent venous thrombosis: warfarin versus heparin.
    Barker AF
    N Engl J Med; 1980 Mar; 302(13):753. PubMed ID: 7354793
    [No Abstract]   [Full Text] [Related]  

  • 51. Prevention of recurrent venous thrombosis: warfarin versus heparin.
    Clarke-Pearson DL
    N Engl J Med; 1980 Mar; 302(13):752-3. PubMed ID: 7354792
    [No Abstract]   [Full Text] [Related]  

  • 52. A ten year study of heparin therapy for thrombophlebitis in ambulatory patients.
    Stillman RM; Chapa L; Stark ML; Malik LN; Keates JR; Sawyer PN
    Surg Gynecol Obstet; 1977 Aug; 145(2):193-7. PubMed ID: 877837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison between heparin and a heparin analogue (sodium pentosan polysulphate) in the initial treatment of deep vein thrombosis. Preliminary communication.
    Bergqvist D; Falke P; Jaroszewski H; Lamme S
    Vasa; 1986; 15(1):77-80. PubMed ID: 2421498
    [No Abstract]   [Full Text] [Related]  

  • 54. Successful treatment of ileofemoral venous thrombosis following cardiac catheterization.
    Whittaker M; Kerr RV
    Thorax; 1973 Nov; 28(6):794-6. PubMed ID: 4787993
    [No Abstract]   [Full Text] [Related]  

  • 55. Rheumatoid arthritis and hypercoagulable state.
    Smith RE; Theisen AL
    Am J Med Sci; 1990 Jul; 300(1):43-4. PubMed ID: 2372020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Significance of determining fibrinogen content during heparin therapy of pregnant women suffering from thrombophlebitis].
    Zelinskaia Ts; Zelinskiĭ M
    Akush Ginekol (Mosk); 1967 May; 43(5):28-30. PubMed ID: 5611899
    [No Abstract]   [Full Text] [Related]  

  • 57. Dermatitis induced by warfarin.
    Kwong P; Roberts P; Prescott SM; Tikoff G
    JAMA; 1978 May; 239(18):1884-5. PubMed ID: 147950
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter: Increased warfarin requirement during mercaptopurine therapy: a new drug interaction.
    Spiers AS; Mibashan RS
    Lancet; 1974 Jul; 2(7874):221-2. PubMed ID: 4135641
    [No Abstract]   [Full Text] [Related]  

  • 59. Concurrent initiation of heparin and warfarin therapy.
    Self TH; Bauman JH; Brown JR; Bickers WJ; Wood CA
    Am Heart J; 1981 Sep; 102(3 Pt 1):470-1. PubMed ID: 7270397
    [No Abstract]   [Full Text] [Related]  

  • 60. Warfarin and hydroxyethylrutosides in deep vein thrombosis.
    Eastham RD; Perham TG; Pocock PV
    Br Med J; 1972 Nov; 4(5838):491. PubMed ID: 4653895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.